BRIEF-IBT Reports Q3 Operating Loss Of SEK 20.7 Mln

0

Nov 13 (Reuters) – Infant Bacterial Therapeutics AB : * LOOKING AHEAD, WE INTEND TO INTENSIFY PREPARATIONS FOR OUR ANTICIPATED LAUNCH OF IBP-9414 * Q3 2026 NET SALES SEK 0, OPERATING LOSS SEK -20.7

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)